Careers  |  Sign In  |  Register  |   Twitter

Latest in Nephrology

Reuters Health • The Doctor's Channel Daily Newscast

Renin-angiotensin blockade helpful in heart failure with renal disease

NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study suggests. The study found that being prescribed an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor...

Reuters Health • The Doctor's Channel Daily Newscast

Novel short-term bicarbonate regimen shows promise for CIN prevention

NEW YORK (Reuters Health) – For prevention of contrast-induced nephropathy (CIN), volume supplementation with sodium chloride 0.9% for 24 hours was more effective than a 7-hour regimen of sodium bicarbonate in a randomized study conducted in Europe. “Twenty-four hour sodium chloride 0.9% 1ml/kg/h is...

Reuters Health • The Doctor's Channel Daily Newscast

Fenofibrate safe in type 2 diabetes and moderate renal impairment

NEW YORK (Reuters Health) – Fenofibrate is safe to use in patients with type 2 diabetes and moderate renal impairment, researchers conclude in a report online December 30 in Diabetes Care. Fenofibrate’s propensity to elevate plasma creatinine is “one of the major hindrances to more widespread...